Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)

1990-472X

Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации

11595

10.18499/1990-472X-2026-27-1-%p

Embryonic Rhabdomyosarcoma of the Prostate in a 3-Year-Old Child with Urinary Tract Infection in Palliative Care

Istin

Alexander

Assistant Professor of Infectious Diseases and Clinical Immunologyistin2013@yandex.ruLesneva

Vera

MD, Associate Professor, Head of the Department of Faculty and Palliative Pediatricslvsmed@yandex.ruGaponenko

Anna

Assistant Professor of Faculty and Palliative Pediatricsgaponenko.a.n@yandex.ruAgeeva

Irina

the residentirina.ageeva.98@mail.ru

N.N. Burdenko Voronezh State Medical University of the Russian Ministry of Health

06042026

271

03042026

2026

Rhabdomyosarcoma (RMS) is one of the most aggressive soft tissue tumors in children. RMS accounts for 4% of all malignant neoplasms in children aged 0-14 years and about 50% of all soft tissue sarcomas. RMS develops from embryonic mesenchymal precursors and, therefore, can be localized in any part of the body. It is believed that the head and neck region, genitourinary tract, and extremities are common sites of primary disease. Stein et al. report that approximately 13%-20% of all cases of rhabdomyosarcoma are most commonly located in the bladder and prostate gland. The mortality rate for rhabdomyosarcoma varies greatly depending on age, location, and histology. Alterio and his colleagues reported the highest five-year survival rate in children aged one to four years, which was 77%. Our study presents a clinical case with a fatal outcome.

Rhabdomyosarcoma, children, urogenital area, palliative care

Рабдомиосаркома, дети, урогенитальная зона, паллиативная помощь.

1. Pastore G, Peris-Bonet R, Carli M, Martínez-García C, Sánchez de Toledo J, Steliarova-Foucher E. Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2136-49. DOI: 10.1016/j.ejca.2006.05.016

2. Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR. Soft tissue sarcomas. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD; 1999: 111-24.

3. Возможности мультимодального лечения метастатической формы рабдомиосаркомы предстательной железы / О. Б. Карякин, С. В. Башкатов, О. В. Терехов [и др.] // Онкоурология. – 2010. – № 2. – С. 63-69. – EDN PUJHWB. [Vozmozhnosti mul'timodal'nogo lechenija metastaticheskoj formy rabdomiosarkomy predstatel'noj zhelezy / O. B. Karjakin, S. V. Bashkatov, O. V. Terehov [i dr.] // Onkourologija. – 2010. – № 2. – S. 63-69. – EDN PUJHWB.] (in Russ.) https://doi.org/10.17650/1726-9776-2010-6-2-63-68

4. Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 5thed. Philadelphia: Lippincott Williams & Wilkins; 2006: 971-1001. https://doi.org/10.1097/00043426-200105000-00008

5. Bisogno G, Anderson J. Soft tissue sarcoma. In: Estlin EJ, Gilberston RJ, Wynn RF, eds. Pediatric hematology and oncology. Scientific principles and clinical practice. Wiley-Blackwell; 2010: 216-34. DOI 10.1002/cncr.20159

6. Crozier E, Rihani J, Koral K, Cope-Yokoyama S, Rakheja D, Ulualp SO. Embryonal rhabdomyosarcoma of the auricle in a child. Pediatr Int. 2012;54(6):945-7. https://doi.org/10.1111/j.1442-200x.2012.03621.x